Skip to content

Reducing Sedentary Behaviour in Young Adults at Risk of Diabetes

An Intervention to Decrease Sedentary Behaviour in Young Adults at Risk of type2 Diabetes Mellitus - Project STAND

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01301196
Acronym
STAND
Enrollment
189
Registered
2011-02-23
Start date
2010-10-31
Completion date
2012-03-31
Last updated
2011-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

sedentary behaviour, diabetes, structured education, 18-30 years olds, family history of T2DM or CVD, BMI ≥ 25 (≥23 for south Asians)

Brief summary

Excessive periods of time spent sitting may be a risk factor for diabetes. Current lifestyles encourage large amounts of sitting (sedentary behaviour) through increasing car use, computers, and appealing screen-based home entertainment systems. Methods to help change such behaviours are now needed, particularly for those with a high risk of developing a chronic disease, such as diabetes. The investigators propose to decrease sedentary behaviour in a multi-ethnic group of young adults at risk of diabetes through an educational intervention (attending a workshop and having prompts). If successful, this could have significant public health benefits given the widespread nature of sedentary behaviour.

Detailed description

The rising prevalence of obesity and sedentary behaviour has lead to an epidemic of Type 2 Diabetes (T2DM). As the health and economic costs of T2DM continue to increase, there is an urgent need for an effective lifestyle intervention to prevent the development of T2DM. Our group have previously developed successful structured education programmes: DESMOND improved lifestyle, depression, illness beliefs, weight and CV risk in adults with T2DM; PREPARE increased activity levels and reduced 2 hour glucose values in people with pre-diabetes. Project STAND will assess the effect of theory driven structured education, facilitated using automated technology, on sedentary behaviour and health outcomes in young adults at risk of T2DM. Participants will be randomised to a control (C) or intervention (I) group, the latter given structured education, based on the PREPARE and DESMOND programmes, with the aim of reducing sedentary behaviour. The structured education programme will incorporate movement technology to facilitate participant feedback and self-monitoring.This will be the first UK trial to address sedentary behaviour change in a population of younger adults at risk of T2DM. Our results will provide a platform for the development of a range of future multidisciplinary interventions in this rapidly expanding high-risk population.

Interventions

3h attendance at educational workshop plus self-monitoring

Sponsors

University Hospitals, Leicester
CollaboratorOTHER
Loughborough University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* aged 18-30 years old * family history of T2DM or CVD (first degree relative) * BMI ≥ 25 (≥ 23 for south Asians)

Design outcomes

Primary

MeasureTime frameDescription
Sedentary behaviour12 monthsSedentary behaviour (time \< 100 counts/min as assessed by 1-week accelerometry, using the new Actigraph GT3X) at 12 months

Secondary

MeasureTime frameDescription
Psychosocial indicators12 monthsIllness perceptions (brief IPQ), efficacy beliefs
Biomarkers12 monthsFasting and 2h glucose, blood lipid profile, insulin, HbA1c, hsCRP, TNFα, IL-6, and IL-6
Screen time12 monthsself-reported screen-time (TV, computers, games)
Self-reported behaviour12 monthsTime in motorised transport, physical activity (accelerometer and IPAQ questionnaire)
Biological measures12 monthsBody weight, waist circumference, blood pressure

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026